Proteomic and functional comparison between human induced and embryonic stem cells

Alejandro J. Brenes,Eva Griesser,Linda V Sinclair,Lindsay Davidson,Alan R Prescott,Francois Singh,Elizabeth K.J Hogg,Carmen Espejo-Serrano,Hao Jiang,Harunori Yoshikawa,Melpomeni Platani,Jason Swedlow,Doreen A Cantrell,Angus I Lamond

DOI: https://doi.org/10.1101/2021.10.20.464767

2024-07-08

Abstract:Human induced pluripotent stem cells (hiPSCs) have great potential to be used as alternatives to embryonic stem cells (hESCs) in regenerative medicine and disease modelling, thereby avoiding many of the ethical issues arising from the use of embryo-derived cells. However, despite clear similarities between the two cell types, it is likely they are not identical. In this study, we characterise the proteomes of multiple hiPSC and hESC lines derived from independent donors. We find that while hESCs and hiPSCs express a near identical set of proteins, they show consistent quantitative differences in the expression levels of a wide subset of proteins. hiPSCs have increased total protein content, while maintaining a comparable cell cycle profile to hESCs. The proteomic data show hiPSCs have significantly increased abundance of vital cytoplasmic and mitochondrial proteins required to sustain high growth rates, including nutrient transporters and metabolic proteins, which correlated with phenotypic differences between hiPSCs and hESCs. Thus, higher levels of glutamine transporters correlated with increased glutamine uptake, while higher levels of proteins involved in lipid synthesis correlated with increased lipid droplet formation. Some of the biggest metabolic changes were seen in proteins involved in mitochondrial metabolism, with corresponding enhanced mitochondrial potential, shown experimentally using high-resolution respirometry. hiPSCs also produced higher levels of secreted proteins, including ECM components and growth factors, some with known tumorigenic properties, as well as proteins involved in the inhibition of the immune system. Our data indicate that reprogramming of human fibroblasts to iPSCs effectively restores protein expression in cell nuclei to a state comparable to hESCs, but does not similarly restore the profile of cytoplasmic and mitochondrial proteins, with consequences for cell phenotypes affecting growth and metabolism. The data improve understanding of the molecular differences between induced and embryonic stem cells, with implications for potential risks and benefits for their use in future disease modelling and therapeutic applications.

Systems Biology

What problem does this paper attempt to address?

This paper aims to address the differences in proteomics and functions between human induced pluripotent stem cells (hiPSCs) and human embryonic stem cells (hESCs). Although hiPSCs are similar to hESCs in many aspects and have great potential in regenerative medicine and disease modeling, it is still questionable whether they are exactly the same. Through detailed proteomic analysis, researchers hope to understand the specific differences in protein expression levels between these two cell types, especially how these differences affect cell growth, metabolism and other biological characteristics.

Specifically, the researchers compared the proteomes of multiple hiPSCs and hESCs lines from different donors and found the following main issues:

1. **Differences in total protein content**: The total protein content in hiPSCs is significantly higher than that in hESCs, which may be related to the higher growth rate of hiPSCs.

2. **Differences in nutrient transporters and metabolic proteins**: The expression levels of proteins related to amino acid, glucose and lactate transport in hiPSCs are increased, which may lead to an enhanced ability of hiPSCs to take up nutrients. In addition, the proteins related to fatty acid synthesis and lipid droplet formation in hiPSCs are also significantly increased.

3. **Changes in mitochondrial metabolism**: The expression levels of mitochondrial - related proteins in hiPSCs are generally increased, including those involved in the electron transport chain and the tricarboxylic acid cycle, indicating that the mitochondrial metabolic activity of hiPSCs is higher.

4. **Changes in secreted proteins**: The expression levels of secreted proteins in hiPSCs are significantly increased, including extracellular matrix (ECM) proteins, growth factors, protease inhibitors and proteases. These changes may affect the cell microenvironment and may even be related to tumorigenesis.

5. **Increase in immunosuppressive proteins**: The immunosuppressive proteins expressed in hiPSCs are increased, which may help them escape recognition and attack by the immune system.

6. **Differences in nuclear proteins**: The expression level of H1 histone in hiPSCs is decreased, while the expression level of H2 histone is increased. These changes may affect chromatin structure and gene expression regulation.

Through the exploration of these issues, researchers hope to gain a deeper understanding of the molecular differences between hiPSCs and hESCs, so as to evaluate their potential risks and advantages in regenerative medicine and disease modeling.